The iconic rise of Viagra has firmly established as a example of pharmaceutical success, yet its future within the broader market now raises questions about long-term yields . Copycat versions are eroding exclusivity , leading to anxieties that betting on companies closely tied to Viagra's former standing could be a speculative decision , especiall